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Macrophage activation is associated with profound
transcriptional reprogramming. Although much pro-
gress has been made in the understanding of macro-
phage activation, polarization, and function, the
transcriptional programs regulating these pro-
cesses remain poorly characterized. We stimulated
human macrophages with diverse activation signals,
acquiring a data set of 299 macrophage trans-
criptomes. Analysis of this data set revealed a spec-
trum of macrophage activation states extending the
current M1 versus M2-polarization model. Network
analyses identified central transcriptional regulators
associated with all macrophage activation comple-
mented by regulators related to stimulus-specific
programs. Applying these transcriptional programs
to human alveolar macrophages from smokers and
patients with chronic obstructive pulmonary disease
(COPD) revealed an unexpected loss of inflammatory
signatures in COPD patients. Finally, by integrating
murine data from the ImmGen project we propose a
refined, activation-independent core signature for
human and murine macrophages. This resource
serves as a framework for future research into
regulation of macrophage activation in health and
disease.
INTRODUCTION
During the last two decades, a conceptual framework for the
description of macrophage activation has been developed.
According to this framework, macrophages can be polarized
into classically (M1) or alternatively (M2) activated cells repre-
senting two polar extremes of signals computed by macro-
phages (Biswas andMantovani, 2010). TheM1 versusM2model
has been very helpful in describing immune responses during274 Immunity 40, 274–288, February 20, 2014 ª2014 Elsevier Inc.acute infections, allergies, asthma, and obesity (Chinetti-
Gbaguidi and Staels, 2011). However, observations obtained
from macrophages involved in chronic inflammation, chronic
infection, or cancer strongly suggest that the myeloid compart-
ment has a much broader transcriptional repertoire depending
on the different environmental signals received (Boorsma et al.,
2013; Chow et al., 2011; Edin et al., 2012; Hodge et al., 2011;
Lawrence and Natoli, 2011; Martinez et al., 2009; Mosser and
Edwards, 2008; Murray and Wynn, 2011; Reinartz et al., 2013).
Despite a number of genomic studies analyzing macrophage
activation in response to bacteria, TLR ligands, and M1 or M2
stimuli, to date there have been no attempts to reconcile
these observations by building new and integrative models of
macrophage activation (Martinez et al., 2006; McDermott et al.,
2011; Nau et al., 2002; Ramsey et al., 2008).
Transcriptomics has considerably contributed to a better
understanding of immune cell function and regulation. Large
consortia such as the ImmGen consortium (Best et al., 2013;
Bezman et al., 2012; Cohen et al., 2013; Gautier et al., 2012;
Miller et al., 2012) or the Human Immunology Project Consortium
(Poland et al., 2013) compiled extensive data sets and defined a
core transcriptional program for murine tissuemacrophages and
dendritic cells (DCs) under steady-state conditions (Gautier
et al., 2012; Miller et al., 2012). A complementary approach
has been introduced by InnateDB (Breuer et al., 2013). Data on
molecular interactions between proteins of the innate immune
system derived from smaller data sets have been compiled
and can be used to reveal mechanistic insights into immune
cell function (Hume et al., 2010; Mabbott et al., 2010). Unfortu-
nately, meta-analysis of small data sets has been hampered by
several challenges, including differences in the genetic back-
ground of mice and in stimulation conditions and the combina-
tion of in vitro and in vivo data limit or even biasmodel generation
of incongruous data sets (Mabbott et al., 2010). Moreover,
comparative studies have identified substantial differences in
immune-cell gene expression between mice and humans
(Schroder et al., 2012; Shay et al., 2013). Therefore, it remains
to be fully elucidated, how immune cell activation—particularly
in human macrophages—is transcriptionally controlled and to
which degree these pathways are conserved across species
(legend on next page)
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Spectrum Model of Human Macrophage Activation(Murray and Wynn, 2011). Standardizing data acquisition and
assembling larger data sets, such as by the ImmGen con-
sortium (Heng and Painter, 2008), is necessary to answer such
questions.
Several elegant studies have demonstrated the value of
analyzing networks based on expression profiling in macro-
phages (Martinez et al., 2006; Nau et al., 2002; Ramsey et al.,
2008) or T helper 17 (Th17) cells (Ciofani et al., 2012; Yosef
et al., 2013). These studies show how technological and
analytical advances can reveal network structures in immune
cells, e.g., by using algorithms that integrate transcriptome
data with database-stored information. Other approaches that
require large data sets, such as reverse network engineering
(RNE), have previously been used to characterize B cell activa-
tion (Basso et al., 2005) and have been further refined during
the last few years (Marbach et al., 2012). However, so far, RNE
has not been applied to other immune cells most likely due to
the lack of large enough data sets.
In this study, we generated a resource data set to assess tran-
scriptional regulation during human macrophage activation by
comparing a diverse set of stimuli on a singlemicroarray platform
under highly standardized conditions. Network modeling of this
data set led us to extend the current M1 versus M2 polarization
model to a ‘‘spectrum model’’ with at least nine distinct
macrophage activation programs. Further characterization of
individual programs identified transcription factors associated
with particular phenotypes, such as STAT4, which was associ-
ated with stimuli linked to chronic inflammation (TNF, prosta-
glandin E2, TLR2-ligand, ‘‘TPP’’) as seen in granulomatous
diseases (Ciofani et al., 2012; Marino et al., 1997; Reiling et al.,
2002; Shay and Celeste Simon, 2012). Furthermore, we applied
this resource data set to define activation states of human
alveolar tissue macrophages in vivo. Finally, we used our
resource data set to refine the previously suggested coremacro-
phage signature to encompass species differences and account
for the spectrum of macrophage activation.
RESULTS
Extending the Current Model of Macrophage
Polarization
We generated macrophages from human monocytes by differ-
entiation with GM-CSF orM-CSF (Figure 1A) and compared their
transcriptomes with DCs and T, B, and natural killer (NK) cells
(see Figure S1A, Table S1, and Supplemental Information
available online). With coregulation analysis (CRA) to assess
overall sample-to-sample relationships, macrophages were
clearly distinguishable from other cell types including DCs (Fig-Figure 1. Extending Macrophage Polarization to a Spectrum Model
(A) Schema describing the workflow for Figure 1.
(B–G) Correlation networks of 299 macrophage transcriptomes representing 29 c
time points (G).
(H) Self-Organizing Map (SOM) clustering using samples displayed in (E). Clusters
frame.
(I) Matrix of hierarchically clustered Pearson’s correlation coefficient matrix (CCM
probes.
(J) Spectrum model (3D) based on the ten clusters defined in (I) and sample value
(Mb) are set as origin, activation states are represented by colored arrows, x, y, z a
Table S2.
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cytometry (Figures S1F and S1G). To better understand the
complexity of transcriptional regulation after macrophage acti-
vation, we next analyzed the transcriptional programs of macro-
phages activated with 28 different stimuli including pattern
recognition receptor ligands, cytokines, and metabolic cues
(Figure 1A). To determine the overall relationship of these activa-
tion states within the data set, we first applied CRA (Figures 1B–
1G). In agreement with the existing model, a virtual axis was
formed, where macrophages at baseline (Mb) were placed in
between macrophages stimulated with interferon-g (IFN-g)
(M1) and interleukin-4 (IL-4) (M2) (Figure 1B; Movie S1). Adding
other conditions linked to M1 (sLPS, TNF) or M2 (IL-13) polariza-
tion (Biswas andMantovani, 2010) (Figure 1C) did not change the
overall M1 and M2 axis (Figure 1B). Including further M1- and
M2-associated stimuli (IFN-g+TNF, IL-10) increased the vari-
ance in the correlation matrix but the overall bipolar structure
was maintained (Figure 1D). However, when adding stimuli not
linked to either M1 or M2 polarization, such as free fatty acids,
high-density lipoprotein (HDL), or combinations of stimuli associ-
ated with chronic inflammation (Table S1), a spectrum of macro-
phage-activation signatures beyond the initial bipolar axis
became apparent (Figures 1E and 1F). Furthermore, when sam-
ples generated at earlier time points of stimulation were added,
the spectrum of macrophage activation was shown to consist
of a dense network of individual signatures (Figure 1G). To bio-
informatically validate these findings, we applied Self-
Organizing-Map (SOM) clustering (Figure 1H) and correlation
coefficient matrices (CCM) (Figure 1I). Performing SOM clus-
tering on the conditions shown by CRA in Figure 1E revealed
that every stimulus was characterized by a specific cluster struc-
ture (Figure 1H) further supporting the spectrummodel. Similarly,
we did not identify a bipolar structure within the CCM, but rather
a condition-specific spectrum of correlation coefficients in 10
major clusters (Figure 1I). By using the coordinates of the sam-
ples defined by CRA within the 10 clusters defined by CCM to
build sum vectors in three-dimensional space, we propose a
model of macrophage activation best described by a spectrum
of transcriptional programs (Figure 1J). Taken together, these
data clearly extend the current model of M1 versus M2 polariza-
tion to a spectrum model of macrophage activation.
Identification of Genes Specifically Associated with
Distinct Stimuli
We next determined whether the different stimuli could be distin-
guished on the gene level within the complete spectrum of the
model. From all macrophage samples included in the analysis,
we identified 9,498 genes that were expressed in at least oneonditions from end of activation time points (B–F) also including intermediate
with the top up- or downregulated genes for each stimulus are marked with a
) standardized from 2.78 to 2.78 (blue to red) based on 1,000 most variable
s (coordinates) defined by correlation network from (F). Baseline macrophages
xes are in dashed lines with double arrows. See also Figure S1, Movie S1, and
Figure 2. Genes with Selective Expression Associated with Distinct Stimuli
(A) Schema describing the workflow for Figure 2.
(B) Absolute expression counts (mean ± SD) of genes defined by SOM clustering to be highly expressed for a particular stimulation condition. Shown here are
genes enriched in either Mb (baseline), IFN-b, GC, IL4+uLPS, upLPS+IC, PA, IFN-g, IFN-g +TNF, sLPS+IFN-g, or TPP+IFN-b. All other conditions are shown in
Figure S2.
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Spectrum Model of Human Macrophage Activationcondition (Table S1D). We used these genes for SOM clustering,
allowing us to select genes specifically regulated and enriched
for individual stimuli (Figure 2A). In fact, by using this approach
we could identify genes that were selectively elevated in only
one of the stimulation conditions included in our data set. For
example, IFN-b selectively induced ZNF77, while IFN-g selec-
tively induced FEM1C (Figure 2B; Figure S2). However, we also
found stimuli where a single gene was insufficient to distinguish
between closely related conditions, e.g., SERINC2 was induced
by PGE2 but also by PGE2+P3C, suggesting that gene combina-tions are necessary to distinguish complex input signals at the
transcriptional level. Overall, although some input signals might
be associated with the induction of single genes, future studies
will require the assessment of a substantial number of markers
as surrogates for distinct activation programs of macrophages.
Network Analysis Defines Stimulus-Associated
Programs of Macrophage Activation
To investigate stimulus-specific gene sets associated with
the respective macrophage activation programs, we appliedImmunity 40, 274–288, February 20, 2014 ª2014 Elsevier Inc. 277
Figure 3. Activation-Specific Genes Revealed by Weighted Correlation Network Analysis
(A) Schema describing the workflow for Figure 3.
(B) Heatmap showing the correlation of the module eigengene (first principal component; ME) to the traits (stimulation conditions). Blue means negative
correlation; orange means positive correlation.
(legend continued on next page)
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Spectrum Model of Human Macrophage Activationweighted gene coexpression network analysis (WGCNA) (Fig-
ure 3A), which defines transcriptional modules based on
Pearson correlation and determines specific gene-expression
patterns for each of the stimulation conditions (Langfelder and
Horvath, 2008). We identified 49 distinct coexpression modules
containing 27 to 884 genes per module. The expression data
from different genes within each calculated module were used
to determine the module eigengenes (ME, the first principle
component of the respective module), which were correlated
to the 29 experimental conditions. As examples, we visualized
the expression of the eigengenes of modules 8, 15, and 30 (Fig-
ure S3A). The resulting ME-to-condition correlation was then
visualized as a heatmap (Figure 3B, summarized in Tables S2A
and S2B). Whereas the classical M1 and M2 stimuli showed
prominent ME patterns (modules 8 and 15, respectively), other
stimuli clearly displayed divergent patterns further supporting a
spectrum model of macrophage activation. For instance, stimu-
lation with TNF, PGE2, and P3C (TPP, M
TPP) induced a strong
signal in modules 30, 32, and 33, which were not present in
IFN-g or IL-4 stimulated cells. TNF, PGE2, and TLR activation
have been linked to chronic granulomatous inflammation such
as in tuberculosis or granulomatous listeriosis (Marino et al.,
1997; Popov et al., 2006; Shay and Celeste Simon, 2012). Genes
including CD25, COX-2, IL10, and indoleamine 2,3-dioxygenase
(IDO) are expressed in macrophages in human granulomatous
structures and are induced in human macrophages after stimu-
lation with the combination of the aforementioned factors (TNF,
PGE2, TLR2 ligand P3C [TPP, M
TTP]) (Popov et al., 2006; Popov
et al., 2008). This suggests that these host factors shape the
transcriptional program during chronic inflammation.
As a next step, we used the modules correlated with the
specific stimulation conditions IFN-g, IL-4, and TPP to link
respective module genes to biological information. We com-
bined Gene Ontology Enrichment Analysis (GOEA) based on
the module genes followed by network visualization of enriched
GO-terms using BiNGO and EnrichmentMap (Figure 3C; Fig-
ure S3B). This analysis confirmed the major functional differ-
ences between IFN-g and IL-4 differentiated macrophages,
e.g., that an M1 response was associated with induction of
inflammatory response genes, while these genes were depleted
in the M2 response (Figure S3B). More importantly, TPP
signaling induced a gene-expression pattern associated with
chronic inflammation, including GO terms such as ‘‘chronic
inflammatory response.’’ We confirmed our approaches by inter-
rogating these gene sets with the GO analysis, pathway analysis,
and transcription factor (TF) binding prediction tools provided by
InnateDB, with the same outcome (Tables S2C–S2K). As a next
step, we determined TFs within the IFN-g, IL-4, and TPP-associ-
ated modules by using Genomatix and visualized them as corre-
lation networks (Figure 3D). This analysis revealed STAT1 as a
central hub in the IFN-g-condition and STAT6 as a hub in the
IL-4-condition. We also identified additional TFs that are linked
to these activation programs, e.g., STAT2, IRF7, and IRF9s for(C) Network visualization of GOEA of modules 30, 32–33 (positively correlated),
BiNGO and EnrichmentMap. Red nodes represent enriched GO-terms, whereas n
Edge thickness shows overlap of genes between neighbor nodes.
(D) Correlation network ofmodule-specific transcription factors (TFs) (IFN-g: modu
correlation between each TF pair. See also Figure S3 and Table S2.IFN-g activation and IRF4 and the forkhead box proteins
FOXQ1 and FOXD2, which were not previously associated with
the IL-4 activation network. For macrophages stimulated with
TPP, the TF network also included STAT4, as well as TFs asso-
ciated with negative regulation of TLR signaling (HEY1; Hu et al.,
2008), macrophage activation (TGIF1; Ramsey et al., 2008), or
TFs at the interface between inflammation and metabolism
(HIF1A; Shay and Celeste Simon, 2012). Other TFs identified in
this network have not yet been linked to macrophage activation
as determined by pubatlas.org-based literature mining (data not
shown). WGCNA revealed activation-associated gene sets
responsible for important biological functions of different macro-
phage populations. These gene sets harbor specific TF networks
including well-established TFs associated with major activation
programs but also TFs not previously associated with macro-
phage activation programs. Taken together, this large data set
of macrophage activation forms the basis for the establishment
of transcriptional networks that are linked to specific activation
signals in human macrophages.
Distinct Phenotype and Function of Macrophages
Activated by TNF, PGE2, and TLR2 Ligand
We used the stimulation condition TPP (MTPP), which is associ-
ated with chronic inflammation, to demonstrate phenotypic
and functional differences to macrophages stimulated with
IFN-g or IL-4. As demonstrated by CCM (Figure 1I) and WGCNA
(Figure 3), MTPP differed considerably in their genomic signature
from M1 or M2 macrophages. By using differentially expressed
genes (FC > 2, FDR adjusted p value < 0.05) between MTPP
(TPP), M1 (IFN-g), M2 (IL-4), and Mb we identified cell surface
markers expressed selectively on MTPP. A total of 51 cell surface
markers were elevated in MTPP but not M1, M2, or Mb. By using
flow cytometry, we confirmed significantly elevated expression
for CD14, CD23, CD25, CXCR7, and CD197 on MTPP (p value <
0.05), while CD86was elevated on bothM1 andMTPP (Figure 4A).
We also identified a set of TFs induced in MTPP but not in M1 or
M2, among them STAT4. Analysis of STAT4 protein expression
clearly confirmed that STAT4 is only induced in MTPP (Figure 4B).
Further differences between MTPP and macrophages stimulated
with IFN-g (M1) or IL-4 (M2) were observed for soluble effector
molecules where, e.g., CXCL5 secretion was significantly
induced by MTPP and to a lesser extent by M1 (p value < 0.05),
but not M2, and IL-1a was only secreted by MTPP (Figure 4C).
No difference in CD3- and CD28-stimulated T cell proliferation
was observed in the presence of M1- or M2-activated macro-
phages, whereas Mb reduced T cell proliferation although not
statistically significantly (p value < 0.05) (Figure 4D). However,
MTPP showed a strong inhibitory effect, clearly demonstrating
that macrophage activation by TPP induced an effector program
distinct from M1 and M2 macrophages. Because transcriptional
programs are further modulated on posttranscriptional level we
assessed the global spectrum of miRNA expression by
miRNA-Seq (Figure 4E). Again, MTPP clearly differed from M1respectively, 12, 13, and 20 (negatively correlated) for TPP-stimulation using
ode size represents corresponding FDR-adjusted enrichment p value (q value).
les 7-9; IL-4: modules 13-15; TPP: 30, 32–33). Edgewidth shows the Pearson’s
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Figure 4. Phenotypic and Functional Characterization of Macrophages Stimulated with TNF, PGE2, and P3C
(A) Flow cytometry of CD14, CD23, CD25, CD86, CXCR7, CD197, in Mb (dark gray), IFN-g (light blue), IL-4 (red), and TPP (light gray) activated macrophages.
Mean fluorescence intensities (MFI) of at least three independent experiments are shown (mean and SEM; p* < 0.05 Student’s t test).
(B) Immunoblot analysis of STAT4 and b-actin. STAT4 expression was normalized to b-actin expression and set to 100% in MTPP (TPP).
(C) CXCL5 and IL1a in supernatants of macrophage cultures.
(D) T cell activation by CD3 and CD28 beads in presence or absence of macrophages assessed by CFSE dilution.
(E) Heatmap showing fold changes of highly abundant miRNAs up- or downregulated (FC > 2, FDR adjusted p value < 0.05) in M1 (IFN-g) or M2 (IL-4), or MTPP
(TPP) compared to Mb (baseline). Fold changes colored from blue to red.
For Figures 4A–4D, mean ± SEM (p* < 0.05, Student’s t-test) are shown.
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Figure 5. Enrichment of Activation Modules in Human Alveolar Macrophages
(A) Schema describing the workflow for Figure 5.
(B) Correlation network of human alveolar macrophages (n = 100) from two studies (Shaykhiev et al., 2009; Woodruff et al., 2005) using 374 genes differentially
expressed between nonsmokers (n = 39) and smokers (n = 49) or COPD (n = 12) patients (FC > 2.0, FDR adjusted p value < 0.05).
(C) Volcano plots of normalized enrichment scores (NES) and enrichment p values based onGSEA usingWGCNAmodules defined in Figure 3. Shown are data for
the stimuli IFN-g, IL-4, TPP, and palmitic acid (PA). Red circles show gene sets positively significantly enriched (NES > 1, p value < 0.05); blue circles show gene
sets significantly depleted (NES < 1, p value < 0.05).
(legend continued on next page)
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miR-125a-5p expression and a lack of M1- (hsa-miR-23b-3p)
or M2-associated microRNAs (miRNAs) (e.g., hsa-miR-125b-
5p, hsa-miR-99a-5p). Similarly, a set of miRNAswas significantly
reduced inMTPP compared toM1 orM2 activation (FDR adjusted
p value < 0.05). Therefore, macrophages differing in their global
transcriptional program from M1 or M2, such as MTPP macro-
phages, are also phenotypically and functionally distinct, further
supporting the spectrum model of macrophage activation.
Macrophage Activation Model Can Be Used to Predict
Macrophage Programs In Vivo
To address whether specific activation programs such as those
described in Figure 3 can be found in human tissue macro-
phages, we compiled two data sets of human alveolar macro-
phages obtained by bronchoalveolar lavage (Shaykhiev et al.,
2009; Woodruff et al., 2005) consisting of samples from non-
smokers, smokers, and COPD patients. Following filtering
steps, data structure analysis, and data visualization, gene-set
enrichment analysis (GSEA) was performed (Figure 5A). Three
major clusters reflecting the three patient groups were revealed
by CRA (Figure 5B) supporting distinct transcriptional programs
in macrophages from the three groups. Next, stimulus-specific
gene modules identified by WGCNA (Figure 3) were utilized as
49 gene sets from in vitro conditions for enrichment analysis.
As positive controls, we applied GSEA to the comparison of
IFN-g-, IL-4-, TPP-, and palmitic acid (PA)-stimulated macro-
phages with unstimulated macrophages. We calculated normal-
ized enrichment scores (NES), which were plotted against
enrichment p values in a Volcano plot (Figure 5C). As expected,
the highest positive NES and lowest p values were observed for
those gene sets (gene modules) that were most significantly en-
riched (NES > 1, p value < 0.05) in the WGCNA analysis for the
respective stimuli (IFN-g, IL-4, TPP, and PA). We then applied
GSEA to the patient sample groups (smoker, COPD) in compar-
ison to nonsmokers (Figure 5D). Unexpectedly, in smokers a
glucocorticoide (GC)-associated gene module (41, WGCNA)
was most significantly enriched (p value < 0.05) followed by
several gene modules associated with free fatty acid but also
IL-4 and TPP stimulation, suggesting a complex network of
stimuli acting on alveolar macrophages in smokers. In contrast
to previous literature (Shaykhiev et al., 2009), we did not see
an enrichment of IL-4-IL-13-associated signatures in COPD
patients with our data-driven approach (Figure 5D). Rather we
found a complete loss of the profound signature of enriched
modules observed in smokers. Concurrently, the most signifi-
cantly depleted (NES < 1, p value < 0.05) WGCNA module in
COPD patients wasmodule 8 (linked to IFN-g stimulation), which
was also significantly depleted in smokers (Figure 5D). Network
visualization of GOEA further supported complex and profound
transcriptional changes in alveolar macrophages from smokers
while cells from COPD patients were rather characterized by
loss of antigen processing, inflammatory response, and regula-(D) Volcano plots of normalized enrichment scores (NES) and enrichment p values
smokers and COPD patients. Representative results of several permutation runs
(E) Network visualization of GOEA of positively enriched modules (p value < 0.01)
modules (p value < 0.01) for COPD patients (modules 8, 29) using BiNGO and En
represent corresponding FDR-adjusted enrichment p values (q values).
282 Immunity 40, 274–288, February 20, 2014 ª2014 Elsevier Inc.tion of immune response, consistent with a depletion in the
IFN-g linked module (Figure 5E). Applying the WGCNA- and
GSEA-defined macrophage differentiation programs to human
ex vivo tissue macrophages, we have uncovered a hitherto
unexplored biology in alveolar macrophages from smokers
and COPD patients.
Common Denominators of Macrophage Activation
While we clearly extended the concept of macrophage polariza-
tion (M1 versus M2) to a spectrum model, our large data set also
allowed us to define common denominators of macrophage
activation. To define these common macrophage activators,
we used reverse network engineering (RNE) utilizing ARACNe
(Algorithm for the Reconstruction of Accurate Cellular Networks,
Figure 6A) (Margolin et al., 2006). We used the 9498 genes pre-
sent in at least one stimulation condition (Table S1D) to generate
a so-called all-versus-all network (Bonferroni corrected p value
107) by predicting interactions based on mutual information
between each gene pair computed from the expression profiles
(Figure S4A; Table S3A; for further technical details see Supple-
mental Information). We identified 66,744 interactions resulting
in an average degree of connectivity of 14.7, meaning one
gene is involved in 15 transcriptional interactions on average
(Figure 6B; Table S3B; Figure S4B). We confirmed these findings
with a second RNE approach (TINGe, Tool for Inferring Network
of Genes) (Aluru et al., 2013), which demonstrated high similarity
in the number of interactions, the average degree of connectivity
and the rank of hubs based on degrees of connectivity as deter-
mined by ARACNe (Table S3C; Figure S4C). We summarized the
network statistical properties (Figures S4D–S4F), since the entire
network is too complex to be displayed. The top 10% of hub
genes inferred in the network (n = 869 most interconnected
genes) collectively participated in 30,431 interactions (Figure 6B).
In the ten most highly interconnected genes, we identified
FABP5, which has recently been implicated in lipid metabolism
and inflammation crosstalk (Furuhashi et al., 2011), and
TNFAIP6, a negative feedback regulator of myeloid cell activa-
tion (Choi et al., 2011). However, according to a pubatlas.org
search (Table S3D), little is known about the role of the other
most highly interconnected genes during macrophage activa-
tion, suggesting that RNE approaches reveal unknown aspects
of macrophage activation. To further understand the biological
processes of the top 10% of hub genes, we performed GOEA
with visualization of GO enrichment networks by using BiNGO
(Figure 6C; Table S3E). This GO-term network subdivided into
five major clusters, one of which was related to immune
response processes (especially terms associated with ‘‘regula-
tion of activation’’). However, other clusters were associated
with cell death, biosynthetic processes of small molecules, and
metabolic and catabolic processes, which also constitute major
but underappreciated aspects of macrophage activation.
By using the TFCat database (Fulton et al., 2009), we identified
27 TFs in the top 10% hub genes (TFs, Figure 6B). We reasonedof the same gene sets applied to data from alveolar macrophages derived from
of GSEA.
for smokers (modules 41, 6, 21, 16, 39, 5, 19, and 42) and negatively enriched
richmentMap. Red nodes represent enriched GO-terms, node size, and color
Figure 6. Macrophage Activation Network Calculated by ARACNe
(A) Schema describing the workflow for Figure 6.
(B) Visualization of the 10% largest hub genes of the ARACNe predicted macrophage regulatory network (n = 299 transcriptomes). For the top ten genes (highest
degree of connectivity, blue) and TFs, mean expression values (log2, derived from the ten clusters in Figure 1I) are highlighted in red colors. Node size reflects
degree of connectivity.
(C) Network visualization of GOEA using BiNGO and EnrichmentMap on hubs shown in (B). Red nodes represent enriched GO-terms, and node size represent
FDR-adjusted enrichment p value (q value). Edge thickness represents overlap of genes between neighbor nodes.
(legend continued on next page)
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macrophage activation and therefore ranked them by average
expression and generated a network of the top five TFs (JUNB,
NFKB1, HIVEP1, CREB1, and HBP1) (Figure 6D; Table S3F).
Roles in macrophage activation have been established for all
of these TFs, except for the zinc finger protein HIVEP1: JUNB
(part of the AP1 complex), NF-kB (global activator), and
CREB1 (inducing survival signals) (Wen et al., 2010). HBP1 has
been linked to differentiation of malignant myeloid cells and to
the regulation of other important TFs including PU.1, RUNX1,
JUNB, or CEBP (Yao et al., 2005). By using position-weight
matrices, we predicted binding of the 27 TFs to the gene loci
of the top 10% hub genes (Table S3G). Twenty-six out of 27 of
these TFs showed significantly enriched binding prediction
(p value < 0.05).
As a complementary approach, we also applied two gene pri-
oritization tools, ToppGene (Chen et al., 2009) and Endeavour
(Tranchevent et al., 2008) to rank the potential association and
closeness of the top 10% hub genes with macrophage cellular
programs using the macrophage lineage TFs RUNX1 and SPI1
(PU.1) as test genes. Of note, the top 11 ranked genes were
TFs and in total, 20 of the 30 top ranked genes are associated
with transcriptional regulation (Figure 6E). In addition to
NFKB1, JUNB, and CREB1, we identified additional TFs already
associated with macrophage activation (STAT3), as well as other
TFs not yet associated with macrophage activation (HMGA1,
NFE2, ZNF148, SMARCA2, DDX21, MNDA, TBLX1). Several
macrophage-activation markers (e.g., MMP9 and CSF1
[M-CSF]) were also strongly linked to macrophage activation in
this analysis. Furthermore, a strong enrichment of PU.1 binding
and permissive histone marks H3K4me3 at the loci of the 869
major hub genes indicate that these genes are likely to be highly
transcribed during macrophage activation (Figure S5; Supple-
mental Information). Together, this RNE analysis identified five
distinct clusters of biological processes as part of the macro-
phage activation process, confirmed the involvement of known
transcriptional regulators such as NFKB1, and identified unex-
pected yet unexplored candidate regulators.
Refinement of Core Genes of Murine Tissue
Macrophages using Human Macrophage Activation
Signatures
Comparative transcriptomics of immune cells between human
and mouse provides a framework for the use of model systems
in the context of human biology and disease (Shay et al.,
2013). We therefore propose a general strategy for how our
resource of human macrophage transcriptomes can be linked
to murine data (Figure 7A). First, we visualized the expression
of the human orthologs of the ImmGen defined coremacrophage
(Figure 7B) and DC (Figure 7C) genes in human macrophages
and monocyte-derived DCs under the different stimulation con-
ditions. We visualized the expression values as heatmaps of
genes ranked by overall differential expression between human
macrophages and DCs (Figures 7A–7C; Table S4). Within the(D) Subnetworks of the five most highly expressed TFs from all hubs shown in (B).
according to its mean expression (log2) in ten clusters (from Figure 1I).
(E) Top 30 putative candidates after Gene Prioritization (GP) of 869 hubs. Mean e
according to cellular functions. See also Figures S4 and S5 and Table S3.
284 Immunity 40, 274–288, February 20, 2014 ª2014 Elsevier Inc.core signature genes defining murine macrophages, we identi-
fied three groups of genes (Figure 7B). The first group of genes
(1) had high conservation of differential expression between hu-
man macrophages and DCs irrespective of macrophage activa-
tion, whereas the second group of genes (2) was characterized
by loss of differential expression after activation with certain
stimuli. The third group of genes (3) was either not differentially
expressed between human macrophages and DCs or showed
even opposite regulation (Figure 7B). A similar grouping was
found for the core signature genes of DCs (Figure 7C). This
approach identified cell surface markers (CD14, FCGR2A
[CD32], MERTK, FCGR1A [CD64], CD13 [ANPEP]) that distin-
guish human macrophages from both DCs and CD14+ blood
monocytes by flow cytometric analysis (Figure 7D). We propose
that this set of cell surface markers should be used for the
discrimination between macrophages and DCs in both species.
Overall, this comparative transcriptomics approach has refined
the core signatures for macrophages and DCs determined in
mice to make them also applicable to human macrophages.
This will further improve the interpretation of data obtained in
species other than human and will guide animal model design
to better reflect relevant human biology.
DISCUSSION
The generation of this large and unique transcriptomic data set of
human macrophage activation represents an important step
forward in understanding how macrophages integrate and
compute signals from their local microenvironment under inflam-
matory conditions. The extension of macrophage activation from
M1 versus M2 polarization to a spectrum model opens new
avenues to studymacrophage activation in the context of human
diseases. For example, network-based description of global but
also input signal-specific transcriptional programming could
form the basis for further studies linking defined activation pro-
grams with in vivo human macrophage biology. In fact, the
lack of any major inflammatory signals in human alveolar macro-
phages derived from COPD patients was an unexpected—but
from a clinical perspective, highly important—result. This result
might actually reflect clinical observations demonstrating ineffi-
ciency of anti-inflammatory treatment regimens in COPD
patients making it necessary to search for alternative strategies
(Barnes, 2013). A better understanding of the transcriptional
regulation of human macrophages could help to selectively
target specific macrophage subsets therapeutically and thereby
could spare other cell types.
Integratinghumanandmurine transcriptomedatasetswill aid to
prioritize and focus future work in animal models. In this respect,
overlaying our human data onto the ImmGen-derived core signa-
tures of DCs and macrophages classified several genes to be
conserved in expression regulation, whereas others clearly are
not conserved. In the future, these studies have to be extended
comparing macrophages from the same tissues in both
species in homeostasis and pathophysiology. Alternatively, theFirst neighbors are surrounding corresponding TFs. Each gene is multicolored
xpression (log2) from each cluster is displayed as a heatmap. Categorization is
(legend on next page)
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require newmethodologies to study gene regulation in an entirely
human context, and without the respective animal models.
Beyond aspects comparing murine and humanmacrophages,
this resource data set can help to answer open questions con-
cerning differential activation of human macrophages with
closely related stimuli, e.g., ultrapure and standard LPS, which
have been often used synonymously in prior studies. Similarly,
while free fatty acids seem to induce closely related transcrip-
tional programs when compared to the remaining stimulation
conditions, we have clear evidence that saturated and unsatu-
rated fatty acids induce distinct transcriptional responses in
human macrophages (S.V.S., data not shown).
We anticipate this data set of humanmacrophage activation to
serve as a starting point for future studies into human macro-
phage biology. In addition to expanding our understanding of
human macrophage biology, this resource will contribute to a
better understanding of general mechanisms of transcriptional
control, as well as the development of newmathematical models
for signal integration and new therapeutic strategies in human
disease.
EXPERIMENTAL PROCEDURES
Detailed description of all experimental procedures and links to analytical tools
and databases used are provided in Supplemental Information. Abbreviations
and description of bioinformatics tools are summarized in Table S5.
Isolation, In Vitro Culture, and Functional Assessment of Cells under
Study
Buffy coats from healthy donors were obtained according to protocols
accepted by the institutional review board at the University of Bonn (local
ethics votes no. 288/13). Human monocytes, B cells, T cells, and NK cells
(Table S1) were purified from peripheral blood mononuclear cells by MACS
in accordance with the manufacturer’s instructions. Macrophages (Mb, base-
line) were generated from monocytes by stimulation with GM-CSF or M-CSF
for 72 hr and further activated with 28 stimulation conditions (Table S1). DCs
were generated by GM-CSF in presence of IL-4 for 72 hr followed by further
stimulation with uLPS, TNF+PGE2, or aCD40 mAbs+TNF. Cells were pheno-
typically assessed by flow cytometry using cell lineage and activationmarkers.
Expression of STAT4 was measured by immunoblotting. CXCL5 and IL-1a in
cell culture supernatants were assessed by ELISA following the manufac-
turer’s instructions. The influence of macrophages on T cell activation was
measured in an allogeneic mixed lymphocyte reaction where CD3+ T cells
were stimulated with CD3+CD28mAbs in presence or absence of differentially
activated macrophages. T cell proliferation was assessed 72 hr later using the
carboxyfluorescein succinimidyl ester dilution method.
RNA Isolation, Gene Expression Profiling, and Basic Bioinformatical
Analysis
Biotin-labeled cRNA was generated with the TargetAmp Nano-g Biotin-aRNA
Labeling Kit for the Illumina System (Epicenter) and then hybridized to Human
HT-12V3 and Human WG-6V3 Beadchips (Illumina) and scanned on an Illu-
mina iScan or HiScanSQ system. Exported from Genome Studio (Illumina),Figure 7. Expression of murine macrophage and dendritic cell signatu
(A) Schema describing the workflow for Figure 7. M, macrophage.
(B and C) Heatmap (standardized and scaled log2 expression) of human ortholog
signature genes (Miller et al., 2012) in monocytes, 29 macrophage stimulation
TNF+PGE2+P3C.
(D) Flow cytometric analysis for surface markers CD14, CD32, MERTK, CD64, CD
macrophages (Mb, red). Mean fluorescence intensities (MFI) of at least three ind
Table S4.
286 Immunity 40, 274–288, February 20, 2014 ª2014 Elsevier Inc.all array data (n = 384) were imported into Partek Genomics Suite (PGS) prior
to quantile normalization. For all analyses with macrophages only (n = 299),
background signals were calculated resulting in 9,498 unique genes to be
present in at least one macrophage stimulation condition. miRNA- and chro-
matin immunoprecipitation sequencing (ChIP-seq) procedures are described
in detail in Supplemental Information.
Coregulation Networks and Comparative Bioinformatics
To describe the structure within the data set, we primarily performed coregu-
lation analysis (CRA) based on Pearson’s correlation coefficients by using
BioLayout Express3D (Theocharidis et al., 2009) (Figures 1B–G; Table S1B).
We determined ANOVA model-defined variable or differentially expressed
genes. To corroborate a stimulus-specific structure in the data set (Figure 1H)
or to determine genes that are elevated only in one of the tested conditions
(Figure 2), we determined self-organizing maps (SOM) and visualized them
after hierarchical clustering (HC) (SOM-clustering). On the basis of the 1,000
most variable genes within the data set, we calculated Pearson’s correlation
coefficient for all stimulation conditions and visualized the resulting correlation
coefficient matrices (CCM) after HC as a heatmap (Figure 1I). The spectrum
model of macrophage activation was established by grouping the samples
according to the clusters obtained by the CCM analysis, utilizing the 3D coor-
dinates of the individual macrophage samples determined by CRA, calculating
mean vectors for the clusters and plotting the information in a 3D graph using
the coordinates of the baseline macrophages (Mb) as the origin (Figure 1J).
Biological Processes Based on Weighted Gene Coexpression
Network Analysis
To determine biological processes either enriched or depleted in the 28
macrophage stimulation conditions, we first dissected the data set (n = 160
macrophage samples, 72 hr time point) into 49 gene modules by applying
WGCNA (Langfelder and Horvath, 2008) (Table S1B; Table S2). The module
eigengene (ME) corresponding to the first principal component was calculated
for eachmodule and aME-to-condition correlation visualized as heatmap (Fig-
ure 3). For the stimulation conditions IFN-g, IL-4, and TPP (TNF+PGE2+P3C),
the gene modules with highest respective lowest correlation scores were used
to generate and visualize networks based on GO-enrichment analysis (GOEA)
by using BiNGO, EnrichmentMap, andWord Clouding in Cytoscape. Visualiza-
tion of coregulation of TFs of the same modules was performed by BioLayout
Express3D.
Combining WGCNA and Gene Set Enrichment Analysis
To utilize the information from the macrophage activation data set to assess
in vivo biology of macrophages, we developed an approach utilizing the
WGCNA-based gene modules as gene sets for gene-set enrichment analysis
(GSEA, see schema in Figure 5). Two data sets of human alveolar macro-
phages (GSE13896 [Shaykhiev et al., 2009] and GSE2125 [Woodruff et al.,
2005]) comprising samples from 39 nonsmokers, 49 smokers, and 12 COPD
patients were combined. GSEA was performed on 49 WGCNA modules (Fig-
ure 3) in 10,000 permutations by using PGS. Normalized enrichment scores
(NES) together with p values of GSEAwere plotted by Volcano plots comparing
the stimulation conditions IFN-g, IL-4, TPP, and PAwithMb (as positive control
analyses of the overall approach). Similarly, the comparison of nonsmokers
with smokers or COPD patients was visualized by Volcano plots. Enriched
modules (p value < 0.01) were selected to perform GOEA.
Reverse Engineering of the Core Macrophage Activation Network
To determine the central hubs of all stimulation conditions reflecting the
core macrophage-activation network, we applied two information-theoreticre genes in humans
s of murine (B) macrophage signature genes (Gautier et al., 2012) and (C) DCs
conditions, and monocyte-derived DCs (baseline = GM-CSF+IL4). TPP =
13 on humanmonocytes (Mono, blue), baseline DCs (DCb, green), and baseline
ependent experiments (mean and SEM; p* < 0.05 Student’s t test). See also
Immunity
Spectrum Model of Human Macrophage Activationmethods, ARACNe and TINGe. Networks were visualized in a force-directed
layout in Cytoscape, followed with statistical analysis utilizing the plug-in
Network Analysis (Cline et al., 2007). With the cytoscape plug-in
MultiColoredNodes (Warsow et al., 2010) mean expression values of the
most highly interconnected genes and TFs were visualized.
Linking Human Macrophage Activation to ImmGen Core Signatures
Human macrophage samples (n = 166), DCs (n = 33), and monocytes (n = 22)
were compiled and expression values of the human orthologs of the previously
describedmurinemacrophage (Gautier et al., 2012), andDC (Miller et al., 2012)
core signatures were plotted as a heatmap of standardized and scaled log2
values (Figure 7; Table S4).
ACCESSION NUMBERS
Macrophage microarray data, ChIP-Seq data, miRNA-Seq data, and alveolar
macrophage microarray data are accessible via super series GSE47189.
Preprocessed data are also available at an online resource portal (www.
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